ROCKWELL MEDICAL, INC. Inventory, LIFO Reserve, Period Charge
ROCKWELL MEDICAL, INC. (RMTI) reported Inventory, LIFO Reserve, Period Charge of -$425.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReservePeriodCharge · last filed 2026-03-26
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for the quarter ending 2024-12-31 was $111.00K.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for the quarter ending 2023-09-30 was $1.10M, a 269.70% increase year-over-year.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for the quarter ending 2022-12-31 was $303.00K, a 431.58% increase year-over-year.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for fiscal 2025 was -$425.00K, a 200.00% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for fiscal 2024 was $425.00K, a 61.29% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for fiscal 2023 was $1.10M, a 80.00% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. inventory, lifo reserve, period charge for fiscal 2022 was $610.00K, a 317.81% increase from fiscal 2021.
| Period end | Inventory, LIFO Reserve, Period Charge 3 month | Inventory, LIFO Reserve, Period Charge 3 month as first filed | Inventory, LIFO Reserve, Period Charge 6 month | Inventory, LIFO Reserve, Period Charge 9 month | Inventory, LIFO Reserve, Period Charge 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | -$425.00K 10-K · filed 2026-03-26 | ||||
| 2024-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $425.00K 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $314.00K 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.10M derived: sum of 2 quarters · filed 2025-03-20 | $1.10M 10-K · filed 2025-03-20 | ||
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.10M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | ||||
| 2022-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $600.00K derived: sum of 2 quarters · filed 2024-03-21 | $610.00K derived: sum of 3 quarters · filed 2024-03-21 | $610.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $307.00K derived: sum of 2 quarters · filed 2023-11-14 | $307.00K 10-Q · filed 2023-11-14 | $364.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $10.00K 10-Q · filed 2023-08-14 | $67.00K derived: sum of 3 quarters · filed 2023-08-14 | $67.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $57.00K derived: sum of 2 quarters · filed 2023-03-30 | $57.00K derived: sum of 3 quarters · filed 2023-03-30 | $75.00K derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $57.00K derived: sum of 2 quarters · filed 2023-03-30 | $75.00K derived: sum of 3 quarters · filed 2023-03-30 | $146.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $18.00K derived: sum of 2 quarters · filed 2022-11-14 | $89.00K 10-Q · filed 2022-11-14 | $89.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $89.00K 10-Q · filed 2022-08-15 | $89.00K derived: sum of 3 quarters · filed 2022-08-15 | $382.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $71.00K 10-Q · filed 2022-05-16 | $71.00K derived: sum of 2 quarters · filed 2022-05-16 | $364.00K derived: sum of 3 quarters · filed 2022-05-16 | $376.00K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $293.00K derived: sum of 2 quarters · filed 2022-04-08 | $305.00K derived: sum of 3 quarters · filed 2022-04-08 | $305.00K 10-K · filed 2022-04-08 | |
| 2020-09-30 | $293.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $305.00K derived: sum of 2 quarters · filed 2021-11-15 | $305.00K 10-Q · filed 2021-11-15 | $305.00K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $12.00K 10-Q · filed 2021-08-16 | $12.00K derived: sum of 3 quarters · filed 2021-08-16 | $1.09M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2021-05-17 | $1.08M derived: sum of 3 quarters · filed 2021-05-17 | $1.26M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.08M derived: sum of 2 quarters · filed 2021-03-31 | $1.26M derived: sum of 3 quarters · filed 2021-03-31 | $1.27M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.26M derived: sum of 2 quarters · filed 2020-11-09 | $1.27M 10-Q · filed 2020-11-09 | $6.61M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $192.00K 10-Q · filed 2020-08-10 | $5.53M derived: sum of 3 quarters · filed 2020-08-10 | $3.05M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $11.00K 10-Q · filed 2020-05-11 | $5.35M derived: sum of 2 quarters · filed 2020-05-11 | $2.87M derived: sum of 3 quarters · filed 2020-05-11 | $6.75M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $2.86M derived: sum of 2 quarters · filed 2020-03-17 | $6.74M derived: sum of 3 quarters · filed 2020-03-17 | $8.78M 10-K · filed 2020-03-17 | |
| 2018-09-30 | -$2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.40M derived: sum of 2 quarters · filed 2019-11-12 | $3.44M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $3.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $5.93M 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $2.05M 10-Q · filed 2019-05-10 | $1.30M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |